Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8672196 | Journal of Vascular Surgery | 2017 | 10 Pages |
Abstract
Although CCO increases the risk of 30-day stroke/death, in-hospital strokes, and prolonged length of stay after CEA, the 30-day stroke/death rates in symptomatic and asymptomatic patients with CCO remain within the recommended thresholds set by the 14 societies' guideline document. Thus, CCO should not qualify as a high-risk criterion for CEA. Moreover, there is no evidence that patients with CCO have lower stroke/death rates after carotid artery stenting than after CEA. We believe that CEA remains a valid and safe option for patients with CCO and that CCO should not be applied as a criterion to promote carotid artery stenting per se.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alexander B. MS, MD, Peter A. MD, Margriet MD, Sara L. MD, MPH, Sarah E. MD, MPH, Thomas C.F. MD, Gert J. MD, Marc L. MD, Vascular Study Group of New England Vascular Study Group of New England,